• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by CHIEF HUMAN RESOURCES OFFICER Gaucher Anthony

    4/15/25 4:36:46 PM ET
    $TIC
    Get the next $TIC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    GAUCHER ANTHONY

    (Last) (First) (Middle)
    C/O ACUREN CORPORATION
    14434 MEDICAL COMPLEX DRIVE, SUITE 100

    (Street)
    TOMBALL TX 77377

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ACUREN CORP [ TIC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    CHIEF HUMAN RESOURCES OFFICER
    3. Date of Earliest Transaction (Month/Day/Year)
    04/11/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) 04/11/2025 A 20,000 (2) (2) Common Stock 20,000 $0 20,000 D
    Performance Based Restricted Stock Units (3) 04/11/2025 A 40,000 (4) (4) Common Stock 40,000 $0 40,000 D
    Explanation of Responses:
    1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
    2. These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
    3. Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
    4. These performance based restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the result of the performance condition.
    /s/ Fiona Sutherland, Attorney-in-Fact 04/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TIC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TIC

    DatePrice TargetRatingAnalyst
    3/21/2025$13.00Neutral
    UBS
    More analyst ratings

    $TIC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Acuren Corporation Confirms Date for First Quarter 2025 Earnings Release

      Acuren Corporation (NYSE:TIC) (the "Company" or "Acuren"), a leading provider of critical asset integrity services, announced today that it intends to release its financial results for the three months ended March 31, 2025, before the market opens on Thursday, May 15, 2025. First Quarter Webcast and Conference Call Acuren will hold a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Thursday, May 15, 2025. Participants on the call will include Talman Pizzey, Chief Executive Officer, Kristin Schultes, Chief Financial Officer, and Robert A.E. Franklin, Co-Chairman. To listen to the call by telephone, please dial 877-407-0789 or 201-689-8562. Yo

      5/7/25 4:15:00 PM ET
      $TIC
    • Acuren Corporation Announces Results for the Fourth Quarter and Full Year 2024

      - Record full year revenue of $1.1 billion driven by deeper service line penetration with recurring customers, targeted new sales in key markets, and certain pricing initiatives - - Acuren has redomiciled in the U.S. and listed on NYSE American - - Establishes 2025 revenue outlook - Acuren Corporation (NYSE:TIC) ("Acuren" or the "Company"), a leading provider of critical asset integrity services, today reported its financial results for the three months and full year ended December 31, 2024. The presentation of our operating results reflects the Company's acquisition of ASP Acuren Holdings, Inc. ("ASP Acuren" or the "ASP Acuren Acquisition"). The period from July 30, 2024, through Decem

      3/27/25 7:00:00 AM ET
      $TIC
    • Acuren Corporation Confirms Date for Fourth Quarter and Full Year 2024 Earnings Release

      Acuren Corporation (NYSE:TIC) (the "Company" or "Acuren"), a leading provider of asset integrity services, announced today that it intends to release its financial results for the fourth quarter and full year 2024 before the market opens on Thursday, March 27, 2025. Webcast and Conference Call: Acuren will hold a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Thursday March 27, 2025. Participants on the call will include Talman Pizzey, Chief Executive Officer, Kristin Schultes, Chief Financial Officer, and Robert A.E. Franklin, Co-Chairman. Additionally, a slide presentation will accompany the conference call. To listen to the call by tel

      3/24/25 7:15:00 AM ET
      $TIC

    $TIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by CHIEF HUMAN RESOURCES OFFICER Gaucher Anthony

      4 - ACUREN CORP (0002032966) (Issuer)

      4/15/25 4:36:46 PM ET
      $TIC
    • SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Pizzey Talman

      4 - ACUREN CORP (0002032966) (Issuer)

      4/15/25 4:30:08 PM ET
      $TIC
    • SEC Form 4 filed by CHIEF FINANCIAL OFFICER Schultes Kristin B

      4 - ACUREN CORP (0002032966) (Issuer)

      4/15/25 4:30:06 PM ET
      $TIC

    $TIC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Acuren Corporation

      SCHEDULE 13G - ACUREN CORP (0002032966) (Subject)

      5/9/25 4:14:00 PM ET
      $TIC
    • SEC Form 424B3 filed by Acuren Corporation

      424B3 - ACUREN CORP (0002032966) (Filer)

      4/24/25 4:28:55 PM ET
      $TIC
    • Acuren Corporation filed SEC Form 8-K: Other Events

      8-K - ACUREN CORP (0002032966) (Filer)

      4/24/25 4:23:39 PM ET
      $TIC

    $TIC
    Financials

    Live finance-specific insights

    See more
    • Acuren Corporation Confirms Date for First Quarter 2025 Earnings Release

      Acuren Corporation (NYSE:TIC) (the "Company" or "Acuren"), a leading provider of critical asset integrity services, announced today that it intends to release its financial results for the three months ended March 31, 2025, before the market opens on Thursday, May 15, 2025. First Quarter Webcast and Conference Call Acuren will hold a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Thursday, May 15, 2025. Participants on the call will include Talman Pizzey, Chief Executive Officer, Kristin Schultes, Chief Financial Officer, and Robert A.E. Franklin, Co-Chairman. To listen to the call by telephone, please dial 877-407-0789 or 201-689-8562. Yo

      5/7/25 4:15:00 PM ET
      $TIC
    • Acuren Corporation Announces Results for the Fourth Quarter and Full Year 2024

      - Record full year revenue of $1.1 billion driven by deeper service line penetration with recurring customers, targeted new sales in key markets, and certain pricing initiatives - - Acuren has redomiciled in the U.S. and listed on NYSE American - - Establishes 2025 revenue outlook - Acuren Corporation (NYSE:TIC) ("Acuren" or the "Company"), a leading provider of critical asset integrity services, today reported its financial results for the three months and full year ended December 31, 2024. The presentation of our operating results reflects the Company's acquisition of ASP Acuren Holdings, Inc. ("ASP Acuren" or the "ASP Acuren Acquisition"). The period from July 30, 2024, through Decem

      3/27/25 7:00:00 AM ET
      $TIC
    • Acuren Corporation Confirms Date for Fourth Quarter and Full Year 2024 Earnings Release

      Acuren Corporation (NYSE:TIC) (the "Company" or "Acuren"), a leading provider of asset integrity services, announced today that it intends to release its financial results for the fourth quarter and full year 2024 before the market opens on Thursday, March 27, 2025. Webcast and Conference Call: Acuren will hold a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Thursday March 27, 2025. Participants on the call will include Talman Pizzey, Chief Executive Officer, Kristin Schultes, Chief Financial Officer, and Robert A.E. Franklin, Co-Chairman. Additionally, a slide presentation will accompany the conference call. To listen to the call by tel

      3/24/25 7:15:00 AM ET
      $TIC

    $TIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UBS initiated coverage on Acuren Corporation with a new price target

      UBS initiated coverage of Acuren Corporation with a rating of Neutral and set a new price target of $13.00

      3/21/25 8:16:22 AM ET
      $TIC